CME Group 10-Q 2022-03-31
Filed 2022-05-04. 7 sections, 153K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2022
- OR -
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 001-31553
CME GROUP INC.
(Exact name of registrant as specified in its charter)
| Delaware | 36-4459170 | |||||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
| 20 South Wacker Drive | Chicago | Illinois | 60606 | |||||||||||
| (Address of principal executive offices) | (Zip Code) |
(312) 930-1000
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||
| Class A Common Stock | CME | The Nasdaq Stock Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | |||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||||||||||
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No ☒
The number of shares outstanding of each of the registrant’s classes of common stock as of April 13, 2022 was as follows: 359,418,140 shares of Class A common stock, $0.01 par value; 625 shares of Class B-1 common stock, $0.01 par value; 813 shares of Class B-2 common stock, $0.01 par value; 1,287 shares of Class B-3 common stock, $0.01 par value; and 413 shares of Class B-4 common stock, $0.01 par value.
CME GROUP INC.
FORM 10-Q
INDEX
PART I. FINANCIAL INFORMATION
Certain Terms
All references to “options” or “options contracts” in the text of this document refer to options on futures contracts.
Further information about CME Group and its products can be found at http://www.cmegroup.com. Information made available on our website does not constitute a part of this Quarterly Report on Form 10-Q.
Information about Contract Volume and Average Rate per Contract
All amounts regarding contract volume and average rate per contract are for CME Group's listed futures and options on futures contracts unless otherwise noted.
Trademark Information
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. NEX, BrokerTec and EBS are trademarks of various entities of NEX Group Limited (NEX). Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc. ("CME"). All other trademarks are the property of their respective owners.
Forward-Looking Statements
From time to time, in this Quarterly Report on Form 10-Q as well as in other written reports and verbal statements, we discuss our expectations regarding future performance. These forward-looking statements are identified by their use of terms and phrases such as "believe," "anticipate," "could," "estimate," "intend," "may," "plan," "expect" and similar expressions, including references to assumptions. These forward-looking statements are based on currently available competitive, financial and economic data, current expectations, estimates, forecasts and projections about the industries in which we operate and management's beliefs and assumptions. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are:
-
increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities;
-
our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks;
-
our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services, including our ability to provide effective services to the swaps market;
-
our ability to adjust our fixed costs and expenses if our revenues decline;
-
our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers;
-
our ability to expand and globally offer our products and services;
-
changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers;
-
the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others;
-
decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions;
-
changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure;
-
the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business;
-
the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets;
-
our dependence on third-party providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by our third-party providers;
-
volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, credit spreads, equity indices, fixed income instruments and foreign exchange rates;
-
economic, social, political and market conditions, including the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers;
-
the impact of the COVID-19 pandemic and response by governments and other third parties;
-
our ability to accommodate increases in contract volume and order transaction traffic and to implement enhancements without failure or degradation of the performance of our trading and clearing systems;
-
our ability to execute our growth strategy and maintain our growth effectively;
-
our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with our joint venture with IHS Markit and our partnership with Google Cloud;
-
uncertainty related to the transition from LIBOR;
-
our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business;
-
industry and customer consolidation;
-
decreases in trading and clearing activity;
-
the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions;
-
our ability to maintain our brand and reputation; and
-
the unfavorable resolution of material legal proceedings.
For a detailed discussion of these and other factors that might affect our performance, see Item 1A. of our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission on February 25, 2022 and Item 1A. in Part II of this Quarterly Report on Form 10-Q.
Item 1. FINANCIAL STATEMENTS
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(dollars in millions, except par value data; shares in thousands)
| March 31, 2022 | December 31, 2021 | |||||||||||||
| (unaudited) | ||||||||||||||
| Assets | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash and cash equivalents | $ | 2,045.7 | $ | 2,834.9 | ||||||||||
| Marketable securities | 109.6 | 115.0 | ||||||||||||
| Accounts receivable, net of allowance of $5.2 and $5.6 | 608.9 | 434.5 | ||||||||||||
| Other current assets (includes $4.8 and $4.8 in restricted cash) | 503.4 | 427.8 | ||||||||||||
| Performance bonds and guaranty fund contributions | 167,736.7 | 157,949.6 | ||||||||||||
| Total current assets | 171,004.3 | 161,761.8 | ||||||||||||
| Property, net of accumulated depreciation and amortization of $1,070.5 and $1,039.4 | 493.9 | 505.3 | ||||||||||||
| Intangible assets—trading products | 17,175.3 | 17,175.3 | ||||||||||||
| Intangible assets—other, net | 3,463.2 | 3,532.0 | ||||||||||||
| Goodwill | 10,515.8 | 10,528.0 | ||||||||||||
| Other assets (includes $0.5 and $0.5 in restricted cash) | 3,265.2 | 3,277.9 | ||||||||||||
| Total Assets | $ | 205,917.7 | $ | 196,780.3 | ||||||||||
| Liabilities and Equity | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Accounts payable | $ | 80.8 | $ | 48.8 | ||||||||||
| Short-term debt | — | 749.4 | ||||||||||||
| Other current liabilities | 641.1 | 1,650.6 | ||||||||||||
| Performance bonds and guaranty fund contributions | 167,736.7 | 157,949.6 | ||||||||||||
| Total current liabilities | 168,458.6 | 160,398.4 | ||||||||||||
| Long-term debt | 3,437.1 | 2,695.7 | ||||||||||||
| Deferred income tax liabilities, net | 5,381.7 | 5,390.4 | ||||||||||||
| Other liabilities | 903.5 | 896.5 | ||||||||||||
| Total Liabilities | 178,180.9 | 169,381.0 | ||||||||||||
| Shareholders’ Equity: | ||||||||||||||
| Preferred stock, $0.01 par value, 10,000 shares authorized as of March 31, 2022 and 2021; 4,584 issued and outstanding as of March 31, 2022 and December 31, 2021 | — | — | ||||||||||||
| Class A common stock, $0.01 par value, 1,000,000 shares authorized at March 31, 2022 and December 31, 2021; 358,631 and 358,599 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively | 3.6 | 3.6 | ||||||||||||
| Class B common stock, $0.01 par value, 3 shares authorized, issued and outstanding as of March 31, 2022 and December 31, 2021 | — | — | ||||||||||||
| Additional paid-in capital | 22,206.3 | 22,190.3 | ||||||||||||
| Retained earnings | 5,498.9 | 5,151.9 | ||||||||||||
| Accumulated other comprehensive income (loss) | 28.0 | 53.5 | ||||||||||||
| Total CME Group Shareholders’ Equity | 27,736.8 | 27,399.3 | ||||||||||||
| Total Liabilities and Equity | $ | 205,917.7 | $ | 196,780.3 |
See accompanying notes to unaudited consolidated financial statements.
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(dollars in millions, except per share data; shares in thousands)
(unaudited)
| Quarter Ended | ||||||||||||||||||||||||||
| March 31, | ||||||||||||||||||||||||||
| 2022 | 2021 | |||||||||||||||||||||||||
| Revenues | ||||||||||||||||||||||||||
| Clearing and transaction fees | $ | 1,138.1 | $ | 1,007.0 | ||||||||||||||||||||||
| Market data and information services | 151.7 | 144.2 | ||||||||||||||||||||||||
| Other | 56.8 | 102.1 | ||||||||||||||||||||||||
| Total Revenues | 1,346.6 | 1,253.3 | ||||||||||||||||||||||||
| Expenses | ||||||||||||||||||||||||||
| Compensation and benefits | 185.2 | 225.0 | ||||||||||||||||||||||||
| Technology | 45.9 | 48.2 | ||||||||||||||||||||||||
| Professional fees and outside services | 31.8 | 37.4 | ||||||||||||||||||||||||
| Amortization of purchased intangibles | 58.4 | 60.6 | ||||||||||||||||||||||||
| Depreciation and amortization | 33.5 | 37.6 | ||||||||||||||||||||||||
| Licensing and other fee agreements | 80.9 | 64.7 | ||||||||||||||||||||||||
| Other | 51.8 | 54.7 | ||||||||||||||||||||||||
| Total Expenses | 487.5 | 528.2 | ||||||||||||||||||||||||
| Operating Income | 859.1 | 725.1 | ||||||||||||||||||||||||
| Non-Operating Income (Expense) | ||||||||||||||||||||||||||
| Investment income | 73.1 | 30.9 | ||||||||||||||||||||||||
| Interest and other borrowing costs | (42.5) | (41.5) | ||||||||||||||||||||||||
| Equity in net earnings of unconsolidated subsidiaries | 73.3 | 56.2 | ||||||||||||||||||||||||
| Other non-operating income (expense) | (46.7) | (18.4) | ||||||||||||||||||||||||
| Total Non-Operating Income (Expense) | 57.2 | 27.2 | ||||||||||||||||||||||||
| Income before Income Taxes | 916.3 | 752.3 | ||||||||||||||||||||||||
| Income tax provision | 205.3 | 177.5 | ||||||||||||||||||||||||
| Net Income | 711.0 | 574.8 | ||||||||||||||||||||||||
| Less: net (income) loss attributable to non-controlling interests | — | (0.4) | ||||||||||||||||||||||||
| Net Income Attributable to CME Group |
Showing the first 8K of 79K characters. Open the full section
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion is provided as a supplement to, and should be read in conjunction with, the accompanying unaudited consolidated financial statements and notes in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 25, 2022.
References in this discussion and analysis to “we” and “our” are to CME Group Inc. (CME Group) and its consolidated subsidiaries, collectively. References to “exchange” are to Chicago Mercantile Exchange Inc. (CME), the Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX), and Commodity Exchange, Inc. (COMEX), collectively, unless otherwise noted.
RESULTS OF OPERATIONS
Financial Highlights
The following summarizes significant changes in our financial performance for the periods presented.
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| (dollars in millions, except per share data) | 2022 | 2021 | Change | |||||||||||||||||||||||||||||||||||
| Total revenues | $ | 1,346.6 | $ | 1,253.3 | 7 | % | ||||||||||||||||||||||||||||||||
| Total expenses | 487.5 | 528.2 | (8) | |||||||||||||||||||||||||||||||||||
| Operating margin | 63.8 | % | 57.9 | % | ||||||||||||||||||||||||||||||||||
| Non-operating income (expense) | $ | 57.2 | $ | 27.2 | 110 | |||||||||||||||||||||||||||||||||
| Effective tax rate | 22.4 | % | 23.6 | % | ||||||||||||||||||||||||||||||||||
| Net income attributable to CME Group | $ | 711.0 | $ | 574.4 | 24 | |||||||||||||||||||||||||||||||||
| Diluted earnings per common share attributable to CME Group | 1.95 | 1.60 | 22 | |||||||||||||||||||||||||||||||||||
| Cash flows from operating activities | 799.1 | 602.7 | 33 |
Revenues
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| (dollars in millions) | 2022 | 2021 | Change | |||||||||||||||||||||||||||||||||||
| Clearing and transaction fees | $ | 1,138.1 | $ | 1,007.0 | 13 | % | ||||||||||||||||||||||||||||||||
| Market data and information services | 151.7 | 144.2 | 5 | |||||||||||||||||||||||||||||||||||
| Other | 56.8 | 102.1 | (44) | |||||||||||||||||||||||||||||||||||
| Total Revenues | $ | 1,346.6 | $ | 1,253.3 | 7 |
Clearing and Transaction Fees
Futures and Options Contracts
The following table summarizes our total contract volume, revenue and average rate per contract for futures and options. Total contract volume includes contracts that are traded on our exchange and cleared through our clearing house and certain cleared-only contracts. Volume is measured in round turns, which is considered a completed transaction that involves a purchase and an offsetting sale of a contract. Average rate per contract is determined by dividing total clearing and transaction fees by total contract volume. Contract volume and average rate per contract disclosures exclude trading volume for the cash markets business and interest rate swaps volume.
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| 2022 | 2021 | Change | ||||||||||||||||||||||||||||||||||||
| Total contract volume (in millions) | 1,607.1 | 1,331.5 | 21 | % | ||||||||||||||||||||||||||||||||||
| Clearing and transaction fees (in millions) | $ | 1,034.3 | $ | 875.6 | 18 | |||||||||||||||||||||||||||||||||
| Average rate per contract | $ | 0.644 | $ | 0.658 | (2) |
We estimate the following net changes in clearing and transaction fees based on a change in total contract volume and a change in average rate per contract for futures and options during the first quarter of 2022 when compared with the same period in 2021.
| (in millions) | Quarter Ended | |||||||||||||
| Increase due to changes in total contract volume | $ | 177.4 | ||||||||||||
| Decrease due to changes in average rate per contract | (18.7) | |||||||||||||
| Net increase in clearing and transaction fees | $ | 158.7 |
Average rate per contract is impacted by our rate structure, including volume-based incentives; product mix; trading venue, and the percentage of volume executed by customers who are members compared with non-member customers. Due to the relationship between average rate per contract and contract volume, the change in clearing and transaction fees attributable to changes in each is only an approximation.
Contract Volume
The following table summarizes average daily contract volume. Contract volume can be influenced by many factors, including political and economic conditions, the regulatory environment and market competition.
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| (amounts in thousands) | 2022 | 2021 | Change | |||||||||||||||||||||||||||||||||||
| Average Daily Volume by Product Line: | ||||||||||||||||||||||||||||||||||||||
| Interest rates | 12,484 | 10,349 | 21 | % | ||||||||||||||||||||||||||||||||||
| Equity indexes | 7,950 | 6,117 | 30 | |||||||||||||||||||||||||||||||||||
| Foreign exchange | 904 | 852 | 6 | |||||||||||||||||||||||||||||||||||
| Agricultural commodities | 1,474 | 1,471 | — | |||||||||||||||||||||||||||||||||||
| Energy | 2,515 | 2,363 | 6 | |||||||||||||||||||||||||||||||||||
| Metals | 593 | 675 | (12) | |||||||||||||||||||||||||||||||||||
| Aggregate average daily volume | 25,920 | 21,827 | 19 | |||||||||||||||||||||||||||||||||||
| Average Daily Volume by Venue: | ||||||||||||||||||||||||||||||||||||||
| CME Globex | 24,060 | 20,436 | 18 | |||||||||||||||||||||||||||||||||||
| Open outcry | 1,030 | 678 | 52 | |||||||||||||||||||||||||||||||||||
| Privately negotiated | 830 | 713 | 16 | |||||||||||||||||||||||||||||||||||
| Aggregate average daily volume | 25,920 | 21,827 | 19 | |||||||||||||||||||||||||||||||||||
| Electronic Volume as a Percentage of Total Volume | 93% | 94 | % |
Overall market volatility increased throughout the first quarter of 2022 following lower overall volatility in the first quarter of 2021. During the first quarter of 2022, the Federal Reserve's indication of multiple rate increases in 2022 as well as its decision to taper bond purchases resulted in higher volatility within the interest rate market. In addition, equity and energy contract volume increased in the first quarter 2022 when compared with the same period in 2021, largely due to the rising tension and geopolitical uncertainty with Russia and Ukraine. We believe these factors led to the changes in contract volume during the first quarter of 2022, when compared with the same period in 2021.
Interest Rate Products
The following table summarizes average daily contract volume for our key interest rate products.
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| (amounts in thousands) | 2022 | 2021 | Change | |||||||||||||||||||||||||||||||||||
| Eurodollar futures and options: | ||||||||||||||||||||||||||||||||||||||
| Futures expiring within two years | 1,869 | 1,262 | 48 | % | ||||||||||||||||||||||||||||||||||
| Options | 1,489 | 1,106 | 35 | |||||||||||||||||||||||||||||||||||
| Futures expiring beyond two years | 811 | 1,414 | (43) | % | ||||||||||||||||||||||||||||||||||
| SOFR futures and options: | ||||||||||||||||||||||||||||||||||||||
| Futures expiring within two years | 1,043 | 102 | n.m. | |||||||||||||||||||||||||||||||||||
| Futures expiring beyond two years | 156 | 10 | n.m. | |||||||||||||||||||||||||||||||||||
| Options | 39 | — | n.m. | |||||||||||||||||||||||||||||||||||
| U.S. Treasury futures and options: | ||||||||||||||||||||||||||||||||||||||
| 10-Year (1) | 2,855 | 2,941 | (3) | |||||||||||||||||||||||||||||||||||
| 5-Year (1) | 1,742 | 1,480 | 18 | |||||||||||||||||||||||||||||||||||
| 2-Year (1) | 711 | 502 | 41 | |||||||||||||||||||||||||||||||||||
| Treasury Bond (1) | 557 | 688 | (19) | |||||||||||||||||||||||||||||||||||
| Federal Funds futures and options | 414 | 100 | n.m. | |||||||||||||||||||||||||||||||||||
(1) U.S. Treasury futures and options now include respective weekly treasury options that were previously separated under a unique product category. Prior period amounts have been revised to conform to the current period presentation.
n.m. not meaningful
In the first quarter of 2022, overall interest rate contract volume increased when compared with the same period in 2021. We believe this increase in volume resulted from higher interest rate volatility as a result of a change in market expectations regarding the Federal Reserve's interest rate policy, following indication that it is planning multiple rate increases in 2022 as well as its decision to taper bond purchases. The increase in Secured Overnight Financing Rate contract (SOFR) volume is due to more market participants transitioning to the new reference rate.
Equity Index Products
The following table summarizes average daily contract volume for our key equity index products.
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| (amounts in thousands) | 2022 | 2021 | Change | |||||||||||||||||||||||||||||||||||
| E-mini S&P 500 futures and options (1) | 4,477 | 3,490 | 28 | % | ||||||||||||||||||||||||||||||||||
| E-mini Nasdaq 100 futures and options (1) | 2,381 | 1,725 | 38 | |||||||||||||||||||||||||||||||||||
| E-mini Russell 2000 futures and options (1) | 452 | 416 | 9 |
(1) E-mini S&P 500 and Nasdaq 100 futures and options now include respective weekly Micro E-mini options that were previously separated under a unique product category. Prior period amounts have been revised to conform to the current period presentation.
In the first quarter of 2022, equity index contract volume increased when compared with the same period in 2021. Volatility within the broad-based indexes increased as a result of the rising tensions and geopolitical uncertainty with Russia and Ukraine as well as the Federal Reserve's proposed interest rate policy changes for 2022. In addition, a market repricing of certain technology-based stocks contributed to the increase in the E-mini Nasdaq 100 contract volume. We believe these factors led to the overall increase in equity contract volume.
Foreign Exchange Products
The following table summarizes average daily contract volume for our key foreign exchange products.
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| (amounts in thousands) | 2022 | 2021 | Change | |||||||||||||||||||||||||||||||||||
| Euro | 249 | 229 | 8 | % | ||||||||||||||||||||||||||||||||||
| Japanese Yen | 134 | 112 | 20 | |||||||||||||||||||||||||||||||||||
| British Pound | 118 | 100 | 18 | |||||||||||||||||||||||||||||||||||
| Australian dollar | 102 | 120 | (15) | |||||||||||||||||||||||||||||||||||
Overall foreign exchange contract volume increased in the first quarter of 2022 when compared with the same period in 2021. Market volatility increased in early 2022 following low foreign exchange volatility in 2021 as a result of the rising tension and geopolitical uncertainty with Russia and Ukraine as well as the Federal Reserve's proposed policy changes for 2022. We believe these factors led to the overall increase in foreign exchange contract volume.
Agricultural Commodity Products
The following table summarizes average daily contract volume for our key agricultural commodity products.
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| (amounts in thousands) | 2022 | 2021 | Change | |||||||||||||||||||||||||||||||||||
| Corn | 487 | 511 | (5) | % | ||||||||||||||||||||||||||||||||||
| Soybean | 323 | 328 | (1) | |||||||||||||||||||||||||||||||||||
| Wheat | 224 | 197 | 14 | |||||||||||||||||||||||||||||||||||
Overall commodity contract volume was flat in the first quarter of 2022 when compared with the same period in 2021. Corn and soybean contract volumes decreased due to lower volatility as a result of stable prices and demand. However, wheat volume increased due to higher volatility due to uncertainty around wheat exports out of the Ukrainian region following the rising tension and geopolitical uncertainty within that region.
Energy Products
The following table summarizes average daily contract volume for our key energy products.
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| (amounts in thousands) | 2022 | 2021 | Change | |||||||||||||||||||||||||||||||||||
| WTI crude oil | 1,438 | 1,265 | 14 | % | ||||||||||||||||||||||||||||||||||
| Natural gas | 542 | 569 | (5) | |||||||||||||||||||||||||||||||||||
| Refined products | 408 | 382 | 7 | |||||||||||||||||||||||||||||||||||
Overall energy contract volume increased in the first quarter of 2022 when compared with the same period in 2021, largely due to an increase in volatility within the crude oil market. We believe the crude oil market exhibited higher volatility as a result of rising crude oil prices due to rising tensions and geopolitical uncertainty with Russia and Ukraine. This was partially offset by a decrease in natural gas volume due to lower volatility as a result of stabilized prices and market equilibrium. We believe these factors led to the overall increase in energy contract volume.
Metal Products
The following table summarizes average daily volume for our key metal products.
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| (amounts in thousands) | 2022 | 2021 | Change | |||||||||||||||||||||||||||||||||||
| Gold | 390 | 404 | (3) | % | ||||||||||||||||||||||||||||||||||
| Copper | 89 | 120 | (25) | |||||||||||||||||||||||||||||||||||
| Silver | 86 | 128 | (33) |
In the first quarter of 2022, metal contract volume decreased when compared with the same period in 2021. We believe the decrease is attributed to lower overall market volatility within the gold and silver markets. Volatility was higher in 2021, as investors were using gold and other precious metals as safe-haven investments following the COVID-19 pandemic.
Average Rate per Contract
The average rate per contract decreased in the first quarter of 2022 when compared with the same period in 2021. The decrease in the average rate per contract was primarily due to a change in product mix. Interest rate and equity index contract volume increased by 3 percentage points as a percent of total volume, while all other products collectively decreased by 3 percentage points. In general, interest rate and equity index products have a lower rate per contract compared with the remaining contracts. In addition, the average rate per contract decreased due to higher volume-based incentives and discounts on our contracts.
Cash Markets Business
Total clearing and transaction fees revenues in the first quarter of 2022 included $86.7 million of transaction fees attributable to the cash markets business, compared with $115.1 million in the first quarter of 2021. This revenue primarily includes BrokerTec Americas LLC's fixed income volume and EBS's foreign exchange volume. In September 2021, we contributed the net assets of our optimization business to OSTTRA, our new joint venture with IHS Markit, which contributed to a $24.3 million decrease in transaction fees in the first quarter of 2022 when compared with the same period in 2021.
| Quarter Ended March 31, | ||||||||||||||||||||
| (amounts in millions) | 2022 | 2021 | Change | |||||||||||||||||
| BrokerTec fixed income transaction fees | $ | 44.4 | $ | 45.5 | (2) | % | ||||||||||||||
| EBS foreign exchange transaction fees | 42.3 | 45.3 | (7) | % | ||||||||||||||||
| Optimization transaction fees | — | 24.3 | n.m. |
The related average daily notional value for the first quarter of 2022 were as follows:
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| (amounts in billions) | 2022 | 2021 | Change | |||||||||||||||||||||||||||||||||||
| European Repo (in euros) | $ | 320.8 | $ | 287.3 | 12 | % | ||||||||||||||||||||||||||||||||
| U.S. Treasury | 147.4 | 136.0 | 8 | |||||||||||||||||||||||||||||||||||
| Spot FX | 68.1 | 72.7 | (6) |
Overall average daily notional value for the cash markets business increased in the first quarter of 2022 compared with the same period in 2021. The increase in European Repo and U.S. Treasury transactions was largely due to increased volatility as a result of rising tensions and geopolitical conflicts in Russia and Ukraine as well as the Federal Reserve's indication of multiple rate increases in 2022. We believe these factors led to the overall increase in cash market average daily notional value. Despite the increase in average daily notional value, transaction revenue decreased slightly due to the tiered pricing structure and incentive rate programs.
Concentration of Revenue
We bill a substantial portion of our clearing and transaction fees directly to our clearing firms. The majority of clearing and transaction fees received from clearing firms represent charges for trades executed and cleared on behalf of their customers. One individual firm represented approximately 11% of our clearing and transaction fees in the first quarter of 2022. Should a clearing firm withdraw, we believe that the customer portion of the firm’s trading activity would likely transfer to another clearing firm of the exchange. Therefore, we do not believe we are exposed to significant risk from the ongoing loss of revenue received from or through a particular clearing firm.
Other Sources of Revenue
During the first quarter of 2022, overall market data and information services revenues increased when compared with the same period in 2021, largely due to a price increase for certain products and an increase in certain device counts.
The two largest resellers of our market data represented approximately 33% of our market data and information services revenue in the first quarter of 2022. Despite this concentration, we consider exposure to significant risk of revenue loss to be minimal. In the event that one of these vendors no longer subscribes to our market data, we believe the majority of that vendor’s customers would likely subscribe to our market data through another reseller. Additionally, several of our largest institutional customers that utilize services from our two largest resellers report usage and remit payment of their fees directly to us.
In the first quarter of 2022, the decrease in other revenue when compared with the same period in 2021 was largely attributable to the deconsolidation of the optimization business in September 2021 as part of the contribution of the business's net assets to OSTTRA, our joint venture with IHS Markit. In the first quarter of 2021, the optimization business generated $42.5 million of other revenue. The decrease is also due to a decline in custody fees on non-cash collateral.
Expenses
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| (dollars in millions) | 2022 | 2021 | Change | |||||||||||||||||||||||||||||||||||
| Compensation and benefits | $ | 185.2 | $ | 225.0 | (18) | % | ||||||||||||||||||||||||||||||||
| Technology | 45.9 | 48.2 | (5) | |||||||||||||||||||||||||||||||||||
| Professional fees and outside services | 31.8 | 37.4 | (15) | |||||||||||||||||||||||||||||||||||
| Amortization of purchased intangibles | 58.4 | 60.6 | (4) | |||||||||||||||||||||||||||||||||||
| Depreciation and amortization | 33.5 | 37.6 | (11) | |||||||||||||||||||||||||||||||||||
| Licensing and other fee agreements | 80.9 | 64.7 | 25 | |||||||||||||||||||||||||||||||||||
| Other | 51.8 | 54.7 | (5) | |||||||||||||||||||||||||||||||||||
| Total Expenses | $ | 487.5 | $ | 528.2 | (8) |
Operating expenses decreased by $40.7 million in the first quarter of 2022 when compared with the same period in 2021. The following table shows the estimated impacts of key factors resulting in the change in operating expenses:
| Quarter Ended, March 31, 2022 | ||||||||||||||||||||||||||
| Amount of Change | Change as a Percentage of Total Expenses | |||||||||||||||||||||||||
| (dollars in millions) | ||||||||||||||||||||||||||
| Salaries, benefits and employer taxes | $ | (25.0) | (5) | % | ||||||||||||||||||||||
| Employee separation and retention costs | (9.5) | (2) | ||||||||||||||||||||||||
| Non-qualified deferred compensation | (8.3) | (2) | ||||||||||||||||||||||||
| Foreign currency exchange rate fluctuation | (6.7) | (1) | ||||||||||||||||||||||||
| Professional fees and outside services | (5.6) | (1) | ||||||||||||||||||||||||
| Bonus | 4.6 | 1 | ||||||||||||||||||||||||
| Licensing and other fee agreements | 16.2 | 3 | ||||||||||||||||||||||||
| Other expenses, net | (6.4) | (1) | ||||||||||||||||||||||||
| Total decrease | $ | (40.7) | (8) | % |
Decreases in operating expenses in the first quarter of 2022 when compared with the same period in 2021 were as follows:
-
Salaries, benefits and employer taxes were lower during the first quarter of 2022 when compared to the same period in 2021 due to a net decrease in headcount since March 31, 2022, including the contribution of employees from CME Group's optimization businesses to the new joint venture with IHS Markit in September 2021.
-
Employee separation and retention costs were lower during the first quarter of 2022 due to a lower reduction in workforce compared to the same period in 2021.
-
A decrease in our non-qualified deferred compensation liability during the first quarter of 2022, the impact of which does not affect net income because of an equal and offsetting change in investment income, contributed to a decrease in compensation and benefits expense.
-
In the first quarter of 2022, we recognized a net gain of $4.3 million, compared with a net loss of $2.4 million in the same period in 2021, due to currency exchange rate fluctuations. Gains and losses from exchange rate fluctuations are recognized in the consolidated statements of net income when subsidiaries with a U.S. dollar functional currency hold certain monetary assets and liabilities denominated in foreign currencies.
-
Professional fees and outside services expenses decreased due to a greater reliance on consultants for platform integrations, information security and systems enhancements in the first quarter of 2021 as well as a reduction in legal fees related to our business activities and product offerings. The decrease in professional fees was partially offset by an increase in Google-related consulting fees that occurred as a result of CME Group's partnership with Google Cloud, which began in November 2021.
Increases in operating expenses in the first quarter of 2022 when compared with the same period in 2021 were as follows:
-
Bonus expense increased in the first quarter of 2022 largely due to performance relative to our 2022 cash earnings target when compared with our first quarter of 2021 performance relative to our 2021 cash earnings target.
-
An increase in licensing and other fee agreements expense was due to higher volumes for certain equity products in the first quarter of 2022 compared to the same period in 2021.
Non-Operating Income (Expense)
| Quarter Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| (dollars in millions) | 2022 | 2021 | Change | |||||||||||||||||||||||||||||||||||
| Investment income | $ | 73.1 | $ | 30.9 | 136 | % | ||||||||||||||||||||||||||||||||
| Interest and other borrowing costs | (42.5) | (41.5) | 2 | |||||||||||||||||||||||||||||||||||
| Equity in net earnings of unconsolidated subsidiaries | 73.3 | 56.2 | 30 | |||||||||||||||||||||||||||||||||||
| Other non-operating income (expense) | (46.7) | (18.4) | 155 | |||||||||||||||||||||||||||||||||||
| Total Non-Operating | $ | 57.2 | $ | 27.2 | 110 |
Investment income. In the first quarter of 2022 when compared with the same period in 2021, there was an increase in earnings from cash performance bond and guaranty fund contributions that are reinvested due to higher reinvestment balances as well as higher rates of interest earned in the cash account at the Federal Reserve Bank of Chicago following an interest rate hike in early 2022.
Equity in net earnings (losses) of unconsolidated subsidiaries. In the first quarter of 2022, we recognized our share of net earnings on our investment in OSTTRA, our new joint venture with IHS Markit that was formed in September 2021. Higher income generated from our S&P/Dow Jones Indices LLC (S&P/DJI) business venture also contributed to an increase in equity in net earnings of unconsolidated subsidiaries in the first quarter of 2022 when compared with the same period in 2021.
Other income (e**xpense). In the first quarter of 2022 when compared with the same period in 2021, we recognized higher expense related to the distribution of interest earned on performance bond collateral reinvestments to the clearing firms caused by higher interest income earned on our reinvestment during the period due to a higher Federal Funds rate in early 2022.
Income Tax Provision
The following table summarizes the effective tax rates for the periods presented:
| 2022 | 2021 | |||||||||||||
| Quarter ended March 31 | 22.4 | % | 23.6 | % | ||||||||||
The overall effective tax rate decreased in the first quarter of 2022 when compared with the same period in 2021. The effective tax rate was lower in the first quarter of 2022 due to a benefit recognized for the settlement of various tax audits.
Liquidity and Capital Resources
Sources and Uses of Cash*.* Net cash provided by operating activities increased in the first quarter of 2022 when compared with the same period in 2021 largely due to an increase in trading volume and revenue. Net cash used in investing activities was lower during the first quarter of 2022 when compared with the same period in 2021 largely due to payments made in early 2021 to purchase non-controlling interests as well as a decrease in purchases of property in the first quarter of 2022. Cash provided by financing activities was lower during the first quarter of 2022 when compared with the same period in 2021 due to a smaller increase in cash performance bonds and guaranty fund contributions.
Debt Instruments*.* The following table summarizes our debt outstanding at March 31, 2022:
| (in millions) | Par Value | ||||
| Fixed rate notes due May 2023, stated rate of 4.30% | € | 15.0 | |||
| Fixed rate notes due March 2025, stated rate of 3.00% (1) | $ | 750.0 | |||
| Fixed rate notes due June 2028, stated rate of 3.75% | $ | 500.0 | |||
| Fixed rate notes due March 2032, stated rate of 2.65% | $ | 750.0 | |||
| Fixed rate notes due September 2043, stated rate of 5.30% (2) | $ | 750.0 | |||
| Fixed rate notes due June 2048, stated rate of 4.15% | $ | 700.0 | |||
(1)We maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable on the notes effectively became fixed at a rate of 3.11%.
(2)We maintained a forward-starting interest rate swap agreement that modified the interest obligation associated with these notes so that the interest payable effectively became fixed at a rate of 4.73%.
We maintain a $2.3 billion multi-currency revolving senior credit facility with various financial institutions, which matures in November 2026. The proceeds from this facility can be used for general corporate purposes, which includes providing liquidity for our clearing house in certain circumstances at CME Group's discretion and, if necessary, for maturities of commercial paper. As long as we are not in default under this facility, we have the option to increase it up to $3.3 billion with the consent of the agent and lenders providing the additional funds. This facility is voluntarily pre-payable from time to time without premium or penalty. Under this facility, we are required to remain in compliance with a consolidated net worth test, which is defined as our consolidated shareholders' equity at September 30, 2021, giving effect to share repurchases made and special dividends paid during the term of the agreements (and in no event greater than $2.0 billion in aggregate), multiplied by 0.65. We currently do not have any borrowings outstanding under this facility, but any commercial paper balance if or when outstanding can be backstopped against this facility.
We maintain a 364-day multi-currency revolving secured credit facility with a consortium of domestic and international banks to be used in certain situations by the clearing house. The facility provides for borrowings of up to $7.0 billion. We may use the proceeds to provide temporary liquidity in the unlikely event a clearing firm fails to promptly discharge an obligation to CME Clearing, in the event of a liquidity constraint or default by a depositary (custodian for our collateral), in the event of a temporary disruption with the domestic payments system that would delay payment of settlement variation between us and our clearing firms, or in other cases as provided by the CME rulebook. Clearing firm guaranty fund contributions received in the form of cash or U.S. Treasury securities as well as the performance bond assets (pursuant to the CME rulebook) can be used to collateralize the facility. At March 31, 2022, guaranty fund contributions available to collateralize the facility totaled $8.6 billion. We have the option to request an increase in the line from $7.0 billion to $10.0 billion. Our 364-day facility contains a requirement that CME remain in compliance with a consolidated tangible net worth test, defined as CME consolidated shareholder's equity less intangible assets (as defined in the agreement), of not less than $800.0 million. We currently do not have any borrowings outstanding under this facility.
The indentures governing our fixed rate notes, our $2.3 billion multi-currency revolving senior credit facility and our 364-day multi-currency revolving secured credit facility for $7.0 billion do not contain specific covenants that restrict the ability to pay dividends. These documents, however, do contain other customary financial and operating covenants that place restrictions on the operations of the company that could indirectly affect the ability to pay dividends.
At March 31, 2022, we have excess borrowing capacity for general corporate purposes of approximately $2.3 billion under our multi-currency revolving senior credit facility.
At March 31, 2022, we were in compliance with the various covenant requirements of all our debt facilities.
CME Group, as a holding company, has no operations of its own. Instead, it relies on dividends declared and paid to it by its subsidiaries in order to provide the funds which it uses to pay dividends to its shareholders.
To satisfy our performance bond obligation with Singapore Exchange Limited, we may pledge irrevocable standby letters of credit. At March 31, 2022, the letters of credit totaled $330.0 million. We also maintain a $350.0 million line of credit to meet our obligations under this agreement.
The following table summarizes our credit ratings at March 31, 2022:
| Short-Term | Long-Term | |||||||||||||||||||
| Rating Agency | Debt Rating | Debt Rating | Outlook | |||||||||||||||||
| Standard & Poor’s Global Ratings | A1+ | AA- | Stable | |||||||||||||||||
| Moody’s Investors Service, Inc. | P1 | Aa3 | Stable |
Given our cash flow generation, our ability to pay down debt levels and our ability to refinance existing debt facilities if necessary, we expect to maintain an investment grade rating. If our ratings are downgraded below investment grade within certain specified time periods due to a change of control, we are required to make an offer to repurchase our fixed rate notes at a price equal to 101% of the principal amount, plus accrued and unpaid interest. No report of any rating agency is incorporated by reference herein.
Liquidity and Cash Management. Cash and cash equivalents totaled $2.0 billion and $2.8 billion at March 31, 2022 and December 31, 2021, respectively. The balance retained in cash and cash equivalents is a function of anticipated or possible short-term cash needs, prevailing interest rates, our corporate investment policy and alternative investment choices. A majority of our cash and cash equivalents balance is invested in money market mutual funds that invest only in U.S. Treasury securities, U.S. government agency securities and U.S. Treasury security reverse repurchase agreements and short-term bank deposits. Our exposure to credit and liquidity risk is minimal given the nature of the investments. Cash that is not available for general corporate purposes because of regulatory requirements or other restrictions is classified as restricted cash and is included in other current assets or other assets in the consolidated balance sheets.
On May 4, 2022, the board of directors declared a regular quarterly dividend of $1.00 per share for all outstanding common and preferred shares. The dividend will be payable on June 27, 2022 to shareholders of record on June 10, 2022. Assuming no changes in the number of shares outstanding, the second quarter dividend payment will total approximately $363.0 million.
Regulatory Requirements*.* CME is regulated by the CFTC as a Derivatives Clearing Organization (DCO). DCOs are required to maintain capital, as defined by the CFTC, in an amount at least equal to one year of projected operating expenses as well as cash, liquid securities, or a line of credit at least equal to six months of projected operating expenses. CME was designated by the Financial Stability Oversight Council as a systemically important financial market utility under Title VIII of the Dodd-Frank Wall Street Reform and Consumer Protection Act. As a result, CME must comply with CFTC regulations applicable to a systemically important DCO for financial resources and liquidity resources. CME is in compliance with all DCO financial requirements.
CME, CBOT, NYMEX and COMEX are regulated by the CFTC as Designated Contract Markets (DCM). DCMs are required to maintain capital, as defined by the CFTC, in an amount at least equal to one year of projected operating expenses as well as cash, liquid securities or a line of credit at least equal to six months of projected operating expenses. Our DCMs are in compliance with all DCM financial requirements.
BrokerTec Americas LLC is required to maintain sufficient net capital under Securities Exchange Act of 1934, as amended (Exchange Act), Rule 15c3-1 (the Net Capital Rule). The Net Capital Rule focuses on liquidity and is designed to protect securities customers, counterparties, and creditors by requiring that broker-dealers have sufficient liquid resources on hand at all times to satisfy claims promptly. Rule 15c3-3, or the customer protection rule, which complements Rule 15c3-1, is designed to ensure that customer property (securities and funds) in the custody of broker-dealers is adequately safeguarded. By law, both of these rules apply to the activities of registered broker-dealers, but not to unregistered affiliates. The firm began operating as a (k)(2)(i) broker dealer in November 2017 following notification to the Financial Industry Regulatory Authority and the SEC. A company operating under the (k)(2)(i) exemption is not required to lock up customer funds as would otherwise be required under Exchange Act Rule 15c3-3.
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are subject to various market risks, including those caused by changes in interest rates, credit, foreign currency exchange rates and equity prices. There have not been material changes in our exposure to market risk since December 31, 2021. Refer to Item 7A. of CME Group’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 25, 2022, for additional information.
Item 4. CONTROLS AND PROCEDURES
(a) Disclosure Controls and Procedures. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, our disclosure controls and procedures are effective.
(b) Changes in Internal Control Over Financial Reporting. As required by Rule 13a-15(d) under the Exchange Act, the company’s management, including the company’s Chief Executive Officer and Chief Financial Officer, have evaluated the company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) to determine whether any changes occurred during the quarter covered by this quarterly report that have materially affected, or are reasonably likely to materially affect, the company’s internal control over financial reporting. There were no changes in the company’s internal control over financial reporting which occurred during the fiscal quarter ended March 31, 2022, that have materially affected, or are reasonably likely to materially affect, the company’s internal control over financial reporting.
PART II. OTHER INFORMATION
| Item 1. LEGAL PROCEEDINGS |
The disclosure under “Legal and Regulatory Matters” in Note 7. Contingencies in the Notes to Unaudited Consolidated Financial Statements in Item 1 of Part I of this report is incorporated herein by reference. Such disclosure includes updates to the legal proceedings disclosed in the company’s Annual Report on Form 10-K, for the year ended December 31, 2021, filed with the SEC on February 25, 2022.
Item 1A. RISK FACTORS
There have been no material changes in the company's risk factors from those disclosed in the company's Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 25, 2022.
| Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
Issuer Purchases of Equity Securities
| Period | (a) Total Number of Class A Shares Purchased (1) | (b) Average Price Paid Per Share | (c) Total Number of Class A Shares Purchased as Part of Publicly Announced Plans or Programs | (d) Maximum Number (or Approximate Value) that May Yet Be Purchased Under the Plans or Programs (in millions) | ||||||||||||||||||||||
| January 1 to January 31 | 449 | $ | 225.80 | — | $ | — | ||||||||||||||||||||
| February 1 to February 28 | — | — | — | — | ||||||||||||||||||||||
| March 1 to March 31 | 17,856 | 232.09 | — | — | ||||||||||||||||||||||
| Total | 18,305 | $ | 231.94 | — |
(1)Shares purchased consist of an aggregate of 18,305 shares of Class A common stock surrendered in the first quarter of 2022 to satisfy employees’ tax obligations upon the vesting of restricted stock.
Item 6. EXHIBITS
| 4.2 | Tenth Supplemental Indenture (including the form of 2.650% Notes due 2032), dated as of March 8, 2022, between CME Group Inc. and U.S. Bank Trust Company, National Association (incorporated by reference to Exhibit 4.2 to CME Group Inc.’s Current Report on Form 8-K filed with the SEC on March 8, 2022). | |||||||
| 10.1 (1) | Retirement Agreement, effective as of April 12, 2022, between Chicago Mercantile Exchange Inc. and Kevin Kometer. (incorporated by reference to Exhibit 10.1 to CME Group Inc.’s Current Report on Form 8-K filed with the SEC on April 14, 2022). | |||||||
| 31.1 | Section 302 Certification—Terrence A. Duffy | |||||||
| 31.2 | Section 302 Certification—John W. Pietrowicz | |||||||
| 32.1 | Section 906 Certification | |||||||
| 101 | The following materials from CME Group Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022, formatted in Inline XBRL (Xtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Equity, (v) the Consolidated Statements of Cash Flows and (vi) Notes to Unaudited Consolidated Financial Statements, tagged as blocks of text. | |||||||
| 104 | Cover Page Interactive Data File included in the Inline XBRL Document Set for Exhibit 101. | |||||||
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase | |||||||
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document | |||||||
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CME Group Inc. (Registrant) | ||||||||||||||||||||
| Dated: May 4, 2022 | By: | /s/ John W. Pietrowicz | ||||||||||||||||||
| John W. PietrowiczChief Financial Officer & Senior Managing Director FinancePrincipal Financial Offer and Duly Authorized Officer |